Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Allen

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
European Urology|May 4, 2020
Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort StudyVasilis Stavrinides, Francesco Giganti, Bruce Trock, et al.
European Radiology|September 18, 2014
Logistic regression model for diagnosis of transition zone prostate cancer on multi-parametric MRINikolaos Dikaios, Jokha Alkalbani, Harbir Singh Sidhu, et al.
European Urology|April 29, 2020
NeuroSAFE PROOF Randomised Controlled Feasibility Study: Brief Report of Perioperative Outcomes, Histological Concordance, and FeasibilityEoin Dinneen, Aiman Haider, Alex Freeman, et al.
European Radiology|May 20, 2017
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trialFrancesco Giganti, Caroline M Moore, Nicola L Robertson, et al.
European Urology Open Science|March 3, 2025
Applying Focal Therapy to Lesions Detected via Magnetic Resonance Imaging: Delivering Cancer Ablation Beyond the Visibility PhenomenonClement Orczyk, Teresa Marsden, Francesco Giganti, et al.
BJU International|May 21, 2014
Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapyCaroline M Moore, Abel-Rahmene Azzouzi, Eric Barret, et al.
European Urology|May 24, 2020
The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional SeriesArmando Stabile, Clement Orczyk, Francesco Giganti, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 15, 2017
Prostate cancer detection using quantitative T<sub>2</sub> and T<sub>2</sub> -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillanceFrancesco Giganti, Giulio Gambarota, Caroline M Moore, et al.
European Urology Open Science|October 1, 2020
Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic AnalysisJoseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
European Radiology|September 14, 2016
"Textural analysis of multiparametric MRI detects transition zone prostate cancer"Harbir S Sidhu, Salvatore Benigno, Balaji Ganeshan, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
European Urology|May 4, 2020
Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort StudyVasilis Stavrinides, Francesco Giganti, Bruce Trock, et al.
European Radiology|September 18, 2014
Logistic regression model for diagnosis of transition zone prostate cancer on multi-parametric MRINikolaos Dikaios, Jokha Alkalbani, Harbir Singh Sidhu, et al.
European Urology|April 29, 2020
NeuroSAFE PROOF Randomised Controlled Feasibility Study: Brief Report of Perioperative Outcomes, Histological Concordance, and FeasibilityEoin Dinneen, Aiman Haider, Alex Freeman, et al.
European Radiology|May 20, 2017
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trialFrancesco Giganti, Caroline M Moore, Nicola L Robertson, et al.
European Urology Open Science|March 3, 2025
Applying Focal Therapy to Lesions Detected via Magnetic Resonance Imaging: Delivering Cancer Ablation Beyond the Visibility PhenomenonClement Orczyk, Teresa Marsden, Francesco Giganti, et al.
BJU International|May 21, 2014
Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapyCaroline M Moore, Abel-Rahmene Azzouzi, Eric Barret, et al.
European Urology|May 24, 2020
The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional SeriesArmando Stabile, Clement Orczyk, Francesco Giganti, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 15, 2017
Prostate cancer detection using quantitative T<sub>2</sub> and T<sub>2</sub> -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillanceFrancesco Giganti, Giulio Gambarota, Caroline M Moore, et al.
European Urology Open Science|October 1, 2020
Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic AnalysisJoseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
European Radiology|September 14, 2016
"Textural analysis of multiparametric MRI detects transition zone prostate cancer"Harbir S Sidhu, Salvatore Benigno, Balaji Ganeshan, et al.
Pageof 13